Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.33 |
| ▸ | CA12 | O43570 | 3/20 | 0.32 |
| ▸ | CA2 | P00918 | 3/20 | 0.32 |
| ▸ | CA9 | Q16790 | 2/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10583329 | 0.92 | CA1 (0.33) | CA1CA12CA2CA9CA14 | |
| SCHEMBL10875768 | 0.92 | CA1 (0.33) | CA1CA12CA2CA9CA14 | |
| SCHEMBL3279296 | 0.88 | CA1 (0.39) | CA1CA12CA2CA9CA14 | |
| SCHEMBL7770093 | 0.81 | — | — | |
| Hydrochloric Acid SCHEMBL3589378 | 0.79 | DNM1 (0.35) | CA1 | |
| SCHEMBL9579090 | 0.79 | TSHR (0.38) | CA1CA12CA2CA9 | |
| SCHEMBL9112091 | 0.78 | — | — | |
| SCHEMBL4506753 | 0.78 | MGLL (0.36) | — | |
| SCHEMBL10364721 | 0.76 | — | — | |
| SCHEMBL21442584 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0191335-B1 | PREPARATION PROCESS OF (6R)-TETRAHYDRO-L-BIOPTERIN | SHIRATORI PHARMACEUTICAL CO. LTD. (JP) | 1991-08-14 | — | — | EP | claimed |
| EP-0222254-A2 | Nicotinic-acid derivatives | BAYER AG (DE) | 1987-05-20 | — | — | EP | claimed |
| EP-0076199-A2 | Triazoloquinazolones and their salts, process and intermediates for preparing them, their use as medicines and compositions containing them | ROUSSEL-UCLAF (FR) | 1983-04-06 | — | — | EP | claimed |
| CN-115867541-A | Aminopyrimidinone derivatives | 豪夫迈·罗氏有限公司 | 2023-03-28 | — | — | CN | disclosed |
| CN-114133521-A | Preparation method of semicrystalline shape memory polymer and polyurethane elastic fiber | 连云港杜钟新奥神氨纶有限公司 | 2022-03-04 | — | — | CN | disclosed |
| US-10622570-B2 | Organic electroluminescent element | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2020-04-14 | — | — | US | disclosed |
| US-10550393-B2 | Method for stabilizing DNA aptamers | TAGCYX BIOTECHNOLOGIES (JP) | 2020-02-04 | — | — | US | disclosed |
| US-20190088883-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | NIPPON STEEL & SUMIKIN CHEMICAL CO., LTD. (JP) | 2019-03-21 | — | — | US | disclosed |
| EP-3439058-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | Nippon Steel & Sumikin Chemical Co., Ltd. (JP) | 2019-02-06 | — | — | EP | disclosed |
| CN-108602688-A | METHOD FOR PRODUCING VANADIUM DIOXIDE PARTICLES | 柯尼卡美能达株式会社 | 2018-09-28 | — | — | CN | disclosed |
| EP-3144313-A1 | COBALT COMPOUND, RAW MATERIAL FOR FORMING THIN FILM, AND METHOD FOR PRODUCING THIN FILM | Adeka Corporation (JP) | 2017-03-22 | — | — | EP | disclosed |
| EP-0589341-B1 | Process for the preparation von endo/exo-8-N,N-dialkylaminoexo-tricyclo(5.2.1.0 2,6) decane | HOECHST AG (DE) | 1997-01-02 | — | — | EP | disclosed |
| WO-1996000755-A1 | CATHODIC ELECTROCOATING COMPOSITIONS CONTAINING BRANCHED EPOXY AMINE RESINS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1996-01-11 | — | — | WO | disclosed |
| US-5447974-A | Blending an epoxy resin amine adduct, blocking with polyisocyanate crosslinking agent and adding pigment | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1995-09-05 | — | — | US | disclosed |
| US-5427857-A | Improved throw power, corrosion resistance | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1995-06-27 | — | — | US | disclosed |
| EP-0596125-A1 | CONDENSED THIOPHENE COMPOUND AND PHARMACEUTICAL USE THEREOF | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1994-05-11 | — | — | EP | disclosed |
| EP-0589341-A1 | Process for the preparation von endo/exo-8-N,N-dialkylaminoexo-tricyclo(5.2.1.0 2,6) decane | HOECHST AKTIENGESELLSCHAFT (DE) | 1994-03-30 | — | — | EP | disclosed |
| US-4868076-A | AMORPHOUS SILICON-GERMANIUM LAYER AND AMORPHOUS CARBON CONTAINING HYDROGEN LAYER | MINOLTA CAMERA KABUSHIKI KAISHA (JP) | 1989-09-19 | — | — | US | disclosed |
| EP-0222254-A2 | Nicotinic-acid derivatives | BAYER AG (DE) | 1987-05-20 | — | — | EP | disclosed |
| EP-0024510-A1 | Phenoxypropyl amine derivatives, process for their preparation, and pharmaceutical compositions containing them | TEIKOKU HORMONE MFG. CO., LTD. (JP) | 1981-03-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10622570-B2 | Organic electroluminescent element | NR2E3, ESR1, NCOR2 | CA1 2049/4885CA12 2453/4885CA2 1498/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.